Observational studyBMC endocrine disorders2025
Effectiveness of empagliflozin in reducing hypoglycemic events as compared to sulfonylurea in type 2 diabetes patients during fasting in Ramadan: a single-center study.
Zareen Kiran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.